Granules Strengthens ADHD Portfolio with FDA Approval for Lisdexamfetamine Dimesylate Capsules
Mumbai, 30th January 2025 – Granules India Limited, a vertically integrated Indian pharmaceutical company, announced today that...
Tag : Granules
Granules’ Net Zero Commitment Validated and Approved by Science Based Targets Initiative
Granules’ Ambitious Climate Targets Span Near-Term, Long-Term, and Net-Zero Goals, Aligned with the 1.5°C Pathway Bengaluru, November 27, 2024 – Granules India Limited, a leading global pharmaceutical company, has received validation and approval...